Assembly Biosciences, Inc. (ASMB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 381.28M |
| Enterprise Value | 325.46M |
| P/E Ratio | 62.51 |
| PEG Ratio | 0.08 |
| Price/Sales Ratio | 9.1 |
| Price/Book Ratio | 2.12 |
| Enterprise/Revenue | 8.7 |
| Enterprise/EBITDA | 9,579.13 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0 |
| Operating Margin | -0.12 |
| Return On Assets | -0 |
| Return On Equity | -0 |
| Revenue | 72.3M |
| Revenue/Share | 3.97 |
| Gross Profit | 72.17M |
| EBITDA | -5.99M |
| Net Income | -6.12M |
| Diluted EPS | -0.55 |
| Total Cash | 320.36M |
| Total Cash/Share | 16.99 |
| Total Debt | 2.35M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 13.99 |
| Book Value Per Share | 16.21 |
| 52-Week Change | 27.66 |
| 52-Week High | 39.71 |
| 52-Week Low | 20.23 |
| Moving Average 50 Days | 26.97 |
| Moving Average 200 Days | 29.22 |
| Average Volume | 226,000 |
| Shares Outstanding | 19.82M |
| % Held by Institutions | 80.29 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | February 12, 2024 |